Home > Riviste > Minerva Endocrinology > Fascicoli precedenti > Minerva Endocrinology 2021 June;46(2) > Minerva Endocrinology 2021 June;46(2):233-4

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

LETTERS TO THE EDITOR   Freefree

Minerva Endocrinology 2021 June;46(2):233-4

DOI: 10.23736/S2724-6507.21.03441-6

Copyright © 2021 EDIZIONI MINERVA MEDICA

lingua: Inglese

Patients diagnosed with low-risk thyroid cancer during COVID-19 pandemic: what did they ask surgeons?

Pierpaolo TRIMBOLI 1, 2 , Arnoldo PICCARDO 3, Alessandra COSSA 4, Maurilio DEANDREA 5, Anda M. NACIU 6, Gaia TABACCO 6, Ugo CATRAMBONE 7, Giovanni CANALE 8, Lorenzo DANIELE 9, Stefano VALABREGA 4, Andrea PALERMO 6, Carlo BELLOTTI 4

1 Clinic for Endocrinology and Diabetology, Lugano Regional Hospital, Lugano, Switzerland; 2 Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland; 3 Department of Nuclear Medicine, E.O. Ospedali Galliera, Genoa, Italy; 4 Department of Medical and Surgical Sciences, S. Andrea Hospital, Sapienza University, Rome, Italy; 5 Department of Endocrinology, Diabetes and Metabolism, Center for Thyroid Diseases, Mauriziano Hospital, Turin, Italy; 6 Unit of Metabolic Disease, Campus Bio-Medico University, Rome, Italy; 7 Department of Surgery, E.O. Ospedali Galliera, Genoa, Italy; 8 Division of Otolaryngology, Mauriziano Hospital, Turin, Italy; 9 Unit of Pathology, Mauriziano Hospital, Turin, Italy



inizio pagina